Time from symptom onset to treatment and outcomes after thrombolytic therapy

Journal of the American College of Cardiology

Volumn 27, Issue 7, 1996, Pages 1646-1655

  Newby, L Kristin ^a   Rutsch, Wolfgang R ^b   Califf, Robert M ^a   Simoons, Maarten L ^c   Aylward, Philip E ^d   Armstrong, Paul W ^e   Woodlief, Lynn H ^a   Lee, Kerry L ^a   Topol, Eric J ^f   Van De Werf, Frans ^g  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d FLINDERS UNIVERSITY   (Australia)

^e UNIVERSITY OF ALBERTA   (Canada)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BYPASS SURGERY; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SHOCK; STROKE; SURVIVAL;

EID: 0029892528     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00053-8     Document Type: Article

References (40)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
2. Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase vs streptokinase and heparin vs no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
3. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329:383-9.
4. Lincoff AM, Topol EJ. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993;88:1361-74.
5. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786-94.
6. Weaver WD, Cerqueira M, Hallstrom AP, et al, for the Myocardial Infarction Triage and Intervention Project Group. Prehospital-initiated vs hospital-initiated thrombolytic therapy. JAMA 1993;270:1211-6.
7. Koren G, Weiss AT, Hasin Y, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 1985;313:1384-9.
8. Mathey DG, Sheehan FH, Schofer J, Dodge HT. Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. J Am Coll Cardiol 1985;6:518-25.
9. Simoons ML, Serruys PW, Van den Brand M, et al, for the Working Group on Thrombolytic Therapy in Acute Myocardial Infarction of the Netherlands Interuniversity Cardiology Institute. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol 1986;7:717-28.
10. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
11. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-60.
12. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70.
13. Dracup K, Moser DK. Treatment-seeking behavior among those with signs and symptoms of acute myocardial infarction. Heart Lung 1991;20:570-5.
14. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
15. Topol EJ, Califf RM, Lee KL, on behalf of the GUSTO Investigators. More on the GUSTO Trial. N Engl J Med 1994;331:277-8.
16. GUSTO correction. N Engl J Med 1994;331:687.
17. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I findings. N Engl J Med 1985;312:932-6.
18. Langer A, Krucoff MW, Klootwijk P, et al. Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST-segment monitoring substudy. J Am Coll Cardiol 1995;25:1552-7.
19. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994;90:2103-14.
20. Schmidt SB, Borsch MA. The prehospital phase of acute myocardial infarction in the era of thrombolysis. Am J Cardiol 1990;65:1411-5.
21. Hartford M, Herlitz J, Karlson BW, Risenfors M. Components of delay time in suspected acute myocardial infarction with particular emphasis on patient delay. J Intern Med 1990;228:519-23.
22. Clark LT, Bellam SV, Shah AH, Feldman JG. Analysis of prehospital delay among inner-city patients with symptoms of myocardial infarction: implications for therapeutic intervention. J Natl Med Assoc 1992;84:931-7.
23. Leitch JW, Birbara T, Freedman B, Wilcox I, Harris PJ. Factors influencing the time from onset of chest pain to arrival at hospital. Med J Aust 1989;150:6-10.
24. GISSI Avoidable Delay Study Group. Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy: a GISSI-generated study. Arch Intern Med 1995;155:1481-8.
25. Sharkey SW, Brunette DD, Ruiz E, et al. An analysis of time delays preceding thrombolysis for acute myocardial infarction. JAMA 1989;262: 3171-4.
26. Gray D, Keating NA, Murdock J, Skene AM, Hampton JR. Impact of hospital thrombolysis on out-of hospital response to suspected myocardial infarction. Lancet 1993;341:654-7.
27. Meischke H, Ho MT, Eisenberg MS, Schaeffer SM, Larsen MP. Reasons patients with chest pain delay or do not call 911. Ann Emerg Med 1995;25:193-7.
28. Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J 1994;128:255-63.
29. Topol EJ, Califf RM, Vandormael M, et al, and the Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation 1992; 85:2090-9.
30. Sharkey SW, Berger CR, Brunette DD, Henry TD. Impact of the electrocardiogram on the delivery of thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1994;73:550-3.
31. Gore JM, Granger CB, Simoons ML, et al, for the GUSTO-I Investigators. Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial. Circulation 1995;92:2811-8.
32. Herlitz J, Hartford M, Blohm M, et al. Effect of a media campaign on delay times and ambulance use in suspected acute myocardial infarction. Am J Cardiol 1989;64:90-3.
33. Mitic WR, Perkins J. The effect of a media campaign on heart attack delay and decision times. Can J Public Health 1984;75:415-8.
34. Moses HW, Engelking N, Taylor GT, et al. Effect of a two-year public education campaign on reducing response time of patients with symptoms of acute myocardial infarction. Am J Cardiol 1991;68:249-51.
35. Ho MT, Eisenberg MS, Litwin PE, Schaeffer SM, Damon SK. Delay between onset of chest pain and seeking medical care: the effect of public education. Ann Emerg Med 1989;18:727-31.
36. Ornato JP. Role of the emergency department in decreasing the time delay to thrombolytic therapy in acute myocardial infarction. Clin Cardiol 1990;13 Suppl V:V-48-52.
37. Cummings P. Improving the time to thrombolytic therapy for myocardial infarction by using a quality assurance audit. Ann Emerg Med 1992;21:1107-10.
38. McCallum AG, Stafford PJ, Jones C, Vincent R, Perez-Avila C, Chamberlain DA. Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J 1990;11 Suppl F:F48-52.
39. Foster DB, Dufendach JH, Barkdoll CM, Mitchell B. Prehospital recognition of AMI using independent nurse/paramedic 12-lead ECG evaluation: impact on in-hospital times to thrombolysis in a rural community hospital. Am J Emerg Med 1994;12:25-31.
40. Kereiakes DJ, Weaver WD, Anderson JL, et al. Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J 1990;120:773-80.